Gene Delivery
Partnership
Approach
About
News
Blog
Menu
Close
Low-N OpenFold fine-tuning improves peptide design without additional structures
Publications
October 4, 2024
NeurIPS MLSB
TOC LINK
TOC LINK
Publications
Published
October 4, 2024
More like this
Dyno Therapeutics Launches Three Breakthrough Capsid Delivery Vectors for Next-Generation Eye, Muscle and CNS Gene Therapies at the 2025 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Announcements
Dyno Therapeutics
May 14, 2025
Dyno Therapeutics Launches Three Breakthrough Capsid Delivery Vectors for Next-Generation Eye, Muscle and CNS Gene Therapies at the 2025 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Announcements
Dyno Therapeutics
May 14, 2025
Challenges and opportunities of machine-guided capsid engineering for gene therapy
Publications
Cell & Gene Therapy Insights
February 26, 2019
Challenges and opportunities of machine-guided capsid engineering for gene therapy
Publications
Cell & Gene Therapy Insights
February 26, 2019
Dyno Therapeutics Named Emerging Company of the Year at New England Venture Capital Association’s 2021 NEVY Awards
Announcements
December 6, 2021
Dyno Therapeutics Named Emerging Company of the Year at New England Venture Capital Association’s 2021 NEVY Awards
Announcements
December 6, 2021
Dyno Therapeutics Closes $100 Million Series A Financing Led by Andreessen Horowitz to Accelerate AI-powered Gene Therapy Platform
Announcements
May 6, 2021
Dyno Therapeutics Closes $100 Million Series A Financing Led by Andreessen Horowitz to Accelerate AI-powered Gene Therapy Platform
Announcements
May 6, 2021
343 Arsenal St
Watertown, MA 02472
© Dyno 2025
Privacy Policy
Terms + Conditions